Interní Med. 2010; 12(5): 275-279

Hypertenze ve stáří

MUDr.Ivan Řiháček, Ph.D., prof.MUDr.Miroslav Souček, CSc., MUDr.Petr Fráňa, Ph.D., MUDr.Martin Plachý
II. interní klinika FN u sv. Anny a Masarykova univerzita Brno

Ve vyspělých zemích neustále stoupá počet osob ve věku nad 65 roků. Hodnota krevního

tlaku, zejména systolického, se s rostoucím věkem zvyšuje. Starší lidé s hypertenzí mají

vyšší riziko vzniku kardiovaskulárních onemocnění. Bylo prokázáno, že léčba hypertenze

starších osob zlepšuje jejich životní prognózu. Výběr antihypertenziva by se měl odvíjet od

přidružených onemocnění a být stanoven individuálně. Léky první volby jsou nízké dávky

diuretik, ACE inhibitory, sartany a blokátory kalciových kanálů. Léčba by měla začít nízkými

dávkami, které se postupně zvyšují.

Keywords: hypertenze, starší osoby, léčba

Published: June 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Řiháček I, Souček M, Fráňa P, Plachý M. Hypertenze ve stáří. Interní Med. 2010;12(5):275-279.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265 (24): 3255-3264. Go to original source...
    2. Staessen JA, Fagard R, Thijs L, et al. Randomized doubleblind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997; 350: 757-764. Go to original source... Go to PubMed...
    3. Ústav zdravotnických informací a statistiky. http://www.uzis.cz/
    4. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995; 25: 305-313. Go to original source... Go to PubMed...
    5. Kannel WB, Wolf PA, McGEE DL, et al. Systolic blood pressure, arterial rigidity and stroke. The Framingham study. JAMA 1981; 245: 1225-1228. Go to original source... Go to PubMed...
    6. Chobanian AV, Bakris GL, Black HR, et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JNC 7: Complete Reports. Hypertension 2003; 42: 1206-1252. Go to original source... Go to PubMed...
    7. Widimský J, a kol. Hypertenze. 3. vydání, Praha: Triton, 2008: 705.
    8. Souček M, Kára T, a kol. Klinická patofyziologie hypertenze. Grada Publishing, Praha 2002; 647 s.
    9. Wang PS, Avorn J, Brookhart MA, et al. Effects of Noncardiovascular comorbidities on Antihypertensive Use in Elderly Hypertensives. Hypertension 2005; 46: 273-279. Go to original source... Go to PubMed...
    10. Kario K, Pickering G, Umeda Y, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation 2003; 107: 1401-1406. Go to original source... Go to PubMed...
    11. MacMahon S, Rodgers A. The effects of blood pressure reduction in older patients: an overview of five randomized controlled trials in elderly hypertensives. Clin Exp Hypertens 1993; 15: 967-978. Go to original source... Go to PubMed...
    12. Beckett NS, Peters R, Fletcher AE, et al. Treatment of Hypertension in Patients 80 Years of Age or Older. N Engl J Med 2008; 358(18): 1887-1898. Go to original source... Go to PubMed...
    13. Widimský J, Cífková R, Špinar J, a kol. Doporučení diagnostických a léčebných postupů u arteriální hypertenze - verze 2007. Doporučení České společnosti pro hypertenzi. Vnitř Lék 2008; 54(1): 101-118. Go to PubMed...
    14. Progress Collaborative Group. Randomized trial of a perindopril-based blood pressure lowering regiment among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358: 1033-1041. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.